Actinium CMO reports 153,868 RSUs, 250K options
Actinium Pharmaceuticals’ Chief Medical Officer reported initial holdings of RSUs and stock options with long-term vesting schedules.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Actinium Pharmaceuticals, Inc. (ATNM) reported the initial beneficial ownership of its Chief Medical Officer, Steffen Wilhem Heeger, on a Form 3. Heeger holds 153,868 shares of Common Stock in the form of restricted stock units that vest fully on September 2, 2029, and a stock option for 250,000 shares of Common Stock with an exercise price of $1.15 per share, expiring May 28, 2036. According to the disclosure, 28% of these options vest on May 28, 2027, with the remainder vesting in 36 equal monthly tranches thereafter.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Heeger Steffen Wilhem
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| Holding | Common Stock F1 | -- | -- | -- |
Holdings:
Stock Option (Right to Buy) — 250,000 contracts (Direct);
Common Stock — 153,868 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units ("RSUs"). The RSUs vest fully on September 2, 2029.
- F2. 28% of the stock options vest and become exercisable on May 28, 2027, with the remainder vesting and becoming exercisable in 36 equal monthly tranches thereafter.
Key Figures
Restricted stock units: 153,868 shares
Stock option underlying shares: 250,000 shares
Stock option exercise price: $1.15 per share
+2 more
5 metrics
Restricted stock units
153,868 shares
RSUs that vest fully on September 2, 2029, held directly by the Chief Medical Officer
Stock option underlying shares
250,000 shares
Shares of common stock underlying the reported stock option held directly
Stock option exercise price
$1.15 per share
Exercise price for the stock option on 250,000 underlying shares
Stock option expiration date
May 28, 2036
Expiration date for the reported stock option position
Initial option vesting percentage
28%
Portion of the stock options that vest and become exercisable on May 28, 2027
Key Terms
restricted stock units ("RSUs"), vest fully, stock options, exercise price, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs"). The RSUs vest fully on"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vest fully financial
"The RSUs vest fully on September 2, 2029."
stock options financial
"28% of the stock options vest and become exercisable on May 28, 2027"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"exercisePrice": "1.1500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ATNM’s Chief Medical Officer report on this Form 3?
The Chief Medical Officer, Steffen Wilhem Heeger, reported initial beneficial ownership consisting of 153,868 restricted stock units and a stock option for 250,000 shares of Actinium Pharmaceuticals, Inc. common stock, all held as direct ownership.
How many RSUs does the ATNM Chief Medical Officer hold and when do they vest?
Heeger holds 153,868 restricted stock units (RSUs). According to the disclosure, these RSUs vest fully on September 2, 2029, at which time they are scheduled to become fully vested if applicable conditions are met.
What are the key terms of the ATNM stock options held by the Chief Medical Officer?
Heeger holds a stock option (right to buy) for 250,000 shares of Actinium Pharmaceuticals, Inc. common stock with an exercise price of $1.15 per share and an expiration date of May 28, 2036.
What is the vesting schedule for the 250,000 ATNM stock options?
The filing states that 28% of the stock options vest and become exercisable on May 28, 2027, with the remainder vesting and becoming exercisable in 36 equal monthly tranches thereafter, subject to the terms of the award.
Does this ATNM Form 3 indicate any purchases or sales by the Chief Medical Officer?
No. The Form 3 presents holdings only, including restricted stock units and stock options. The structured data report no buy or sell transactions, only positions held after the reporting date.
Is there any indication of a Rule 10b5-1 trading plan in this ATNM Form 3?
No. The structured data show the Rule 10b5-1 plan field as null, and the footnotes describe only vesting schedules for RSUs and stock options, with no reference to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
